Omesti Berhad Q1 2026 Financial Results: Revenue Growth, Corporate Actions, and Business Outlook

Omesti Berhad Q1 2026 Financial Report: Key Investor Insights

Financial Performance Overview

Turnaround in Profitability: Omesti Berhad posted a profit before tax of RM2.386 million for the first quarter ended 31 January 2026, compared to a loss before tax of RM79.246 million in the immediate preceding quarter. This sharp improvement is primarily attributed to progress work in the Business Performance Services division and the absence of significant writedowns and finance costs seen previously.
Revenue Surge: Group revenue for the quarter reached RM27.227 million, a substantial increase of RM18.544 million (213.6%) from RM8.683 million in the preceding quarter. The revenue boost was mainly driven by order fulfilments and progress billing in Business Performance Services and retail sales from Healthcare Services.
Profit Attribution: Of the RM2.386 million profit, RM470,000 is attributable to owners of the parent and RM1.916 million to non-controlling interests.
Earnings Per Share: Basic and diluted earnings per ordinary share stood at 0.02 sen for the current quarter.

Balance Sheet Highlights

Strengthened Equity Position: Total equity increased to RM129.88 million from RM76.91 million as at 31 October 2025, reflecting recapitalisation initiatives including a rights issue and private placement.
Net Assets Per Share: Net assets per share improved to RM0.0543 from RM0.0444.
Cash Position: Cash and cash equivalents rose to RM18.385 million, with RM12.782 million being freely available after excluding fixed deposits pledged to banks.
Borrowings: Total borrowings as at 31 January 2026 are RM11.6 million, representing a significant reduction following repayment from rights issue and private placement proceeds.

Corporate Actions and Capital Management

Rights Issue and Private Placement: Omesti completed a renounceable rights issue of 329,409,407 ordinary shares with 131,763,761 free warrants D on 11 November 2025, raising RM26.35 million. A further private placement of 302,924,400 shares was completed on 26 December 2025, raising RM24.23 million. These exercises have materially strengthened the balance sheet and reduced gearing, setting the stage for lower finance costs going forward.
RPS and Creditor Settlement: The Company settled RM106.44 million in redeemable preference shares (RPS) and RM8.5 million in creditor debts through new share issuance. These moves eliminated substantial liabilities and improved equity.
Share Capital Reduction: The High Court of Malaya approved a RM200 million share capital reduction, which was completed on 5 March 2026. This is expected to further improve the capital structure and shareholder value.
Utilisation of Proceeds: Proceeds from the rights issue and private placement were used for loan repayments, working capital, and funding ongoing and future projects, with unutilised balances placed in the bank.

Business Segment Performance

Business Performance Services: This segment contributed RM20.065 million to group revenue and RM2.972 million to profit before tax, making it the largest revenue and profit generator.
Healthcare Services: Revenue from this segment was RM6.507 million, with a profit before tax contribution of RM24,000. The segment is benefiting from retail sales and secured contracts.
Digital & Infrastructure Services: Revenue was minimal (RM14,000), with a segment loss of RM100,000.
Others: Contributed RM641,000 in revenue and RM140,000 in profit before tax.

Cash Flow and Liquidity

Operating Cash Flow: Net cash used in operating activities was RM27.495 million, mainly due to working capital changes and tax payments.
Investing and Financing Activities: Cash flows from financing activities were positive at RM38.335 million, reflecting proceeds from rights issue and private placement, offsetting negative operating and investing cash flows.
Strong Liquidity Position: The Company’s recapitalisation exercises have ensured a healthy cash balance and reduced reliance on debt.

Litigation and Contingencies

Material Litigation: Ongoing legal proceedings between Formis Network Services Sdn Bhd (FNS) and Suruhanjaya Syarikat Malaysia (SSM) relating to the termination of an outsourcing agreement. SSM is seeking RM49.3 million in damages, but FNS is contesting the claim and has counterclaimed potential damages of up to RM150 million, asserting the termination was unlawful and premature. Proceedings are ongoing and could be material to shareholder value depending on court outcomes.
No Other Material Litigations: Apart from the above, the Group is not engaged in any other material litigation or arbitration.

Other Noteworthy Items

No Dividends Paid: No dividends were paid during the current financial period.
Accounting Policies: The Group adopted several new MFRS amendments, but none had material impact on the financial statements.
Seasonality: Operations were not materially affected by seasonal or cyclical factors.
Capital Commitments: No material capital commitments during the quarter.

Business Outlook

The Group’s recapitalisation exercises have strengthened its financial position and are expected to lower future finance costs.
Revenue and margin recognition from secured contracts in Business Performance Services and Healthcare Services segments have begun, contributing positively to results.
The Group remains actively engaged in pursuing further opportunities in both public and private sectors.
The Board of Directors is cautiously optimistic about improved performance for the remainder of FY2026.

Potential Price-Sensitive Implications for Investors

Turnaround in Profitability: The return to profitability, driven by recapitalisation and improved business segment performance, may positively affect share prices.
Completion of Major Corporate Actions: Rights issue, private placement, RPS and creditor settlements, and share capital reduction have materially improved the Company’s financial health and capital structure, which investors should view as positive.
Litigation Risks: The outcome of ongoing litigation involving FNS and SSM remains a potential risk factor and could impact valuations depending on court judgments and potential damages.
Strong Cash Position and Reduced Gearing: Improved liquidity and reduced reliance on debt may support future growth and stability, which is attractive to investors.
Segmental Growth: Growth in Business Performance Services and Healthcare Services may signal sustained revenue and margin improvements in coming quarters.

Disclaimer

The information contained in this article is derived from the Company’s official financial statements and disclosures. It is intended for informational purposes only and does not constitute investment advice. Investors are urged to conduct their own due diligence and consult professional advisors before making any investment decisions. The Company’s future performance is subject to various risks including market conditions, litigation outcomes, and execution of business strategies.